Literature DB >> 15260933

Chronic pelvic pain syndrome and voiding dysfunction.

Werner W Hochreiter1, Sebastian Z'Brun.   

Abstract

Chronic prostatitis/chronic pelvic pain syndrome is a disease that is mainly characterized by three parameters: pain in the suprapubic and pelvic area, presence or absence of white blood cells in expressed prostatic secretions, and voiding disorders of various degrees. The causative factors underlying this very common condition are poorly understood. Therapeutic options (ie, antimicrobial treatment) often are based on the presence of an inflammatory reaction in the expressed prostatic secretions, but the benefit of recurring or prolonged courses of antimicrobial agents is highly variable. Observations have been made regarding functional and structural changes in the lower urinary tract that are suggestive to have an impact on the pathogenesis of chronic pelvic pain syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15260933     DOI: 10.1007/s11934-004-0056-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  28 in total

1.  Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Daniel A Shoskes; Lawrence Hakim; Gamal Ghoniem; Charles L Jackson
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

2.  Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome.

Authors:  J Q Clemens; R B Nadler; A J Schaeffer; J Belani; J Albaugh; W Bushman
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

3.  Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and "nonbacterial" prostatitis.

Authors:  M A Tanner; D Shoskes; A Shahed; N R Pace
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  How common is prostatitis? A national survey of physician visits.

Authors:  M M Collins; R S Stafford; M P O'Leary; M J Barry
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

5.  Neurourological insights into the etiology of genitourinary pain in men.

Authors:  D H Zermann; M Ishigooka; R Doggweiler; R A Schmidt
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

6.  Micturition in conscious rats with and without bladder outlet obstruction: role of spinal alpha 1-adrenoceptors.

Authors:  O Ishizuka; K Persson; A Mattiasson; A Naylor; M Wyllie; K Andersson
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Diagnosis and treatment of 409 patients with prostatitis syndromes.

Authors:  J J de la Rosette; M R Hubregtse; E J Meuleman; M V Stolk-Engelaar; F M Debruyne
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

8.  Coagulase-negative staphylococcus in chronic prostatitis.

Authors:  J C Nickel; J W Costerton
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

9.  Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy.

Authors:  Petr Hruz; Hansjörg Danuser; Urs E Studer; Werner W Hochreiter
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

10.  Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.

Authors:  Anthony J Schaeffer; Jill S Knauss; J Richard Landis; Kathleen J Propert; Richard B Alexander; Mark S Litwin; J Curtis Nickel; Michael P O'Leary; Robert B Nadler; Michel A Pontari; Daniel A Shoskes; Scott I Zeitlin; Jackson E Fowler; Carissa A Mazurick; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

View more
  1 in total

1.  [Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)].

Authors:  T Bschleipfer; F M E Wagenlehner; W Weidner
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.